232 related articles for article (PubMed ID: 32108042)
1. Identification of Novel Prognosis and Prediction Markers in Advanced Prostate Cancer Tissues Based on Quantitative Proteomics.
Kwon OK; Ha YS; Na AY; Chun SY; Kwon TG; Lee JN; Lee S
Cancer Genomics Proteomics; 2020; 17(2):195-208. PubMed ID: 32108042
[TBL] [Abstract][Full Text] [Related]
2. Proteomics in diagnosis of prostate cancer.
Davalieva K; Polenakovic M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
[TBL] [Abstract][Full Text] [Related]
3. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M
Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962
[TBL] [Abstract][Full Text] [Related]
4. Comparative Proteome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteogenomics.
Kwon OK; Ha YS; Lee JN; Kim S; Lee H; Chun SY; Kwon TG; Lee S
Cancer Genomics Proteomics; 2019; 16(4):273-286. PubMed ID: 31243108
[TBL] [Abstract][Full Text] [Related]
5. The role of proteomics in prostate cancer research: biomarker discovery and validation.
Pin E; Fredolini C; Petricoin EF
Clin Biochem; 2013 Apr; 46(6):524-38. PubMed ID: 23266295
[TBL] [Abstract][Full Text] [Related]
6. Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study.
Larkin SE; Johnston HE; Jackson TR; Jamieson DG; Roumeliotis TI; Mockridge CI; Michael A; Manousopoulou A; Papachristou EK; Brown MD; Clarke NW; Pandha H; Aukim-Hastie CL; Cragg MS; Garbis SD; Townsend PA
Br J Cancer; 2016 Oct; 115(9):1078-1086. PubMed ID: 27685442
[TBL] [Abstract][Full Text] [Related]
7. Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness.
Liu Y; Chen J; Sethi A; Li QK; Chen L; Collins B; Gillet LC; Wollscheid B; Zhang H; Aebersold R
Mol Cell Proteomics; 2014 Jul; 13(7):1753-68. PubMed ID: 24741114
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers for prostate cancer.
Schiffer E
World J Urol; 2007 Dec; 25(6):557-62. PubMed ID: 17690889
[TBL] [Abstract][Full Text] [Related]
9. Comparative Secretome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteomics.
Kwon OK; Jeon JM; Sung E; Na AY; Kim SJ; Lee S
Cancer Genomics Proteomics; 2018; 15(4):279-290. PubMed ID: 29976633
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysis.
Han ZD; Zhang YQ; He HC; Dai QS; Qin GQ; Chen JH; Cai C; Fu X; Bi XC; Zhu JG; Liao DJ; Lu XP; Mo ZY; Zhu YP; Zhong WD
Med Oncol; 2012 Dec; 29(4):2877-88. PubMed ID: 22215415
[TBL] [Abstract][Full Text] [Related]
11. RankProd Combined with Genetic Algorithm Optimized Artificial Neural Network Establishes a Diagnostic and Prognostic Prediction Model that Revealed C1QTNF3 as a Biomarker for Prostate Cancer.
Hou Q; Bing ZT; Hu C; Li MY; Yang KH; Mo Z; Xie XW; Liao JL; Lu Y; Horie S; Lou MW
EBioMedicine; 2018 Jun; 32():234-244. PubMed ID: 29861410
[TBL] [Abstract][Full Text] [Related]
12. Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis.
Al-Ruwaili JA; Larkin SE; Zeidan BA; Taylor MG; Adra CN; Aukim-Hastie CL; Townsend PA
Cancer Genomics Proteomics; 2010; 7(2):93-103. PubMed ID: 20335524
[TBL] [Abstract][Full Text] [Related]
13. The Proteome of Primary Prostate Cancer.
Iglesias-Gato D; Wikström P; Tyanova S; Lavallee C; Thysell E; Carlsson J; Hägglöf C; Cox J; Andrén O; Stattin P; Egevad L; Widmark A; Bjartell A; Collins CC; Bergh A; Geiger T; Mann M; Flores-Morales A
Eur Urol; 2016 May; 69(5):942-52. PubMed ID: 26651926
[TBL] [Abstract][Full Text] [Related]
14. Screening, identification of prostate cancer urinary biomarkers and verification of important spots.
Zhao H; Zhao X; Lei T; Zhang M
Invest New Drugs; 2019 Oct; 37(5):935-947. PubMed ID: 30610587
[TBL] [Abstract][Full Text] [Related]
15. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B
J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer diagnosis and characterization with mass spectrometry imaging.
Kurreck A; Vandergrift LA; Fuss TL; Habbel P; Agar NYR; Cheng LL
Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):297-305. PubMed ID: 29209003
[TBL] [Abstract][Full Text] [Related]
17. Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer.
Davalieva K; Kostovska IM; Kiprijanovska S; Markoska K; Kubelka-Sabit K; Filipovski V; Stavridis S; Stankov O; Komina S; Petrusevska G; Polenakovic M
Prostate; 2015 Oct; 75(14):1586-600. PubMed ID: 26074449
[TBL] [Abstract][Full Text] [Related]
18. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis.
Pang J; Liu WP; Liu XP; Li LY; Fang YQ; Sun QP; Liu SJ; Li MT; Su ZL; Gao X
J Proteome Res; 2010 Jan; 9(1):216-26. PubMed ID: 19894759
[TBL] [Abstract][Full Text] [Related]
19. Comparative Proteomics Uncovers Correlated Signaling Network and Potential Biomarkers for Progression of Prostate Cancer.
Ai J; Lu Y; Wei Q; Li H
Cell Physiol Biochem; 2017; 41(1):1-9. PubMed ID: 28437789
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer.
Barboro P; Repaci E; Rubagotti A; Salvi S; Boccardo S; Spina B; Truini M; Introini C; Puppo P; Ferrari N; Carmignani G; Boccardo F; Balbi C
Br J Cancer; 2009 May; 100(10):1608-16. PubMed ID: 19401687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]